{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for icosapent root_names_stdName in Standardized Name (approximate match)
Status:
Investigational
Source:
NCT04085523: Phase 2 Interventional Completed Achondroplasia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:puxitatug samrotecan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:raludotatug deruxtecan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:epitumomab cituxetan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:trastuzumab rezetecan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pegtarazimod [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tezatabep matraxetan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ifinatamab deruxtecan [INN]
Source URL:
Class:
PROTEIN